Hypoxic Prostate/Muscle Po2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer: Long-Term Results
- 1 March 2012
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 82 (3), e433-e439
- https://doi.org/10.1016/j.ijrobp.2011.05.037
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate CancerUrology, 2009
- Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patientsRadiotherapy and Oncology, 2007
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivationInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Polarographic electrode study of tumor oxygenation in clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Hypoxic prostate/muscle po2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findingsUrology, 2002
- Hypoxia in Breast Cancer: Pathogenesis, Characterization and Biological/Therapeutic ImplicationsWiener Medizinische Wochenschrift, 2002
- Hypoxia in Human Prostate CarcinomaAmerican Journal of Clinical Oncology, 2001
- The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomasInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Intratumoral pO2 predicts survival in advanced cancer of the uterine cervixRadiotherapy and Oncology, 1993